Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Type of study
Language
Document Type
Year range
1.
Case Reports in Infectious Diseases ; : 1-5, 2022.
Article in English | Academic Search Complete | ID: covidwho-1789048

ABSTRACT

We here report a case of COVID-19 with effusion prior to the development of pneumonia in an adult with Down syndrome. Serositis due to rheumatic disease was initially suspected because of a high titer of serum autoantibodies and leukocytopenia;however, SARS-CoV-2 infection was confirmed by reverse transcription polymerase chain reaction on admission after previous negative tests. Several cases of COVID-19 have been associated with autoimmune responses along with some cases of COVID-19 with autoimmune manifestations. Furthermore, patients with Down syndrome have a higher mortality risk from COVID-19 than the general population, and it is believed that a high sensitivity to the interferon response may contribute to the increased severity of the disease. Thus, careful attention should be paid to autoimmune manifestations due to SARS-CoV-2 infection for ensuring a proper and timely diagnosis, especially in patients with Down syndrome. [ FROM AUTHOR] Copyright of Case Reports in Infectious Diseases is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

2.
Mod Rheumatol Case Rep ; 6(1): 10-13, 2022 01 07.
Article in English | MEDLINE | ID: covidwho-1462426

ABSTRACT

We report two cases recovered from coronavirus disease 2019 with rheumatoid arthritis which had been in remission or low disease activity by taking calcineurin inhibitor (CNI). Both cases had moderate to severe pneumonia treated with intravenous dexamethasone or in the severe case remdesivir in addition to it. These cases suggest that the use of CNI may have affected the improvement of severe pneumonia.


Subject(s)
Arthritis, Rheumatoid , COVID-19/drug therapy , Calcineurin Inhibitors , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/therapeutic use , Alanine/analogs & derivatives , Alanine/therapeutic use , Arthritis, Rheumatoid/drug therapy , Calcineurin , Calcineurin Inhibitors/therapeutic use , Dexamethasone/therapeutic use , Humans , Survivors
SELECTION OF CITATIONS
SEARCH DETAIL